2014-02-12 10:26:04 - Chile Pharmaceuticals and Healthcare Report Q3 2013 - a new market research report on companiesandmarkets.com
The lack of vigilance in bioequivalence regulations in Chile has allowed for the proliferation of low quality medicines in the market. These can risk patients´ lives and negatively affect the local pharmaceutical industry´s global competitiveness. Despite the ongoing capacity issues reported by domestic manufacturers, we believe generic drugmakers in Chile need to adopt necessary production processes to guarantee their drug quality.
Headline Expenditure Projections
- Pharmaceuticals: CLP1,603bn (US$3.3bn) in 2012 to CLP1,715bn (US$3.6bn) in 2013; +7.0% in local currency terms and +8.9% in US dollar terms.
- Healthcare: CLP9,825bn (US$20.2bn) in 2012 to CLP10,629bn (US$22.3bn) in 2013; +8.2% in local currency terms and +10.2% in US dollar terms.
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market
Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.